Form 4: Tandem Diabetes Care Executive Reports Stock Transactions
SEC Form 4 Filing
Susan Morrison, EVP & Chief Admin. Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On February 27, 2024, Susan Morrison, EVP & Chief Admin. Officer of Tandem Diabetes Care Inc., reported transactions involving Tandem Diabetes Care Inc. common stock.
- Morrison acquired 407 shares of common stock through the vesting of restricted stock units (RSUs).
- 113 shares were withheld by Tandem Diabetes Care, Inc. to satisfy tax withholding requirements on the vesting of restricted stock units (RSU) at a price of $27.34.
- Following these transactions, Morrison directly owns 15,451 shares of Tandem Diabetes Care Inc. common stock and 406 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, and is a standard practice for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| May 27, 2020 | Date RSUs were awarded pursuant to the 2013 Stock Incentive Plan. |
| May 27, 2021 | First vesting date for 25% of the RSUs. |
| February 27, 2024 | Date of the reported stock transactions (RSU vesting and tax withholding). |
| February 29, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.